“…In RGCs, like other central nervous system (CNS) neurons, the failure to regenerate after injury or disease is multifactorial, including reduced intrinsic axon growth ability in adult neurons [2][3][4][5], tissue destructive inflammatory responses [6], extrinsic glial-associated inhibitory molecules [7][8][9], and insufficient neurotrophic factor support [10][11][12]. Most efforts to improve CNS axon survival and regeneration have focused on overcoming extrinsic glial-associated inhibitors in the injured CNS like Nogo, oligodendrocyte myelin glycoprotein (Omgp), semaphorin 3A, myelin associated glycoprotein, and chondroitin sulfate proteoglycans (CSPGs) [13][14][15][16][17][18][19], increasing deficient neurotrophic factor signaling [10,12,[20][21][22][23], modulating inflammation [24], and manipulating intrinsic signaling molecules like phosphatase and tensin homolog (PTEN) [25,26], SOCS3 [27], and the Krüppel-like family (KLF) family of transcription factors [28,29] among others well reviewed [30]. Addressing extrinsic factors individually or in combination with other extrinsic or intrinsic factors can slow RGC death, promote partial axon regeneration, and in some cases, restore limited visual function in animal models [26].…”